ONCOSWEEP
LIVE

Serial Number

97665270

Owner

Pharus Taiwan, Inc.

Attorney

Chinhwei Chen

First Use Date

Dec 19, 2024

Filing Date

Nov 7, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ONCOSWEEP Trademark

Serial Number: 97665270 • Registration: 7892446

ONCOSWEEP is a trademark filed by Pharus Taiwan, Inc. on November 7, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Pharus Taiwan, Inc.

7F.-7, No. 66, Shengyi 5th Rd.
Zhubei, Hsinchu County 302041 , TW

Entity Type: 03

Trademark Details

Filing Date

November 7, 2022

Registration Date

August 12, 2025

First Use Anywhere

December 19, 2024

First Use in Commerce

December 19, 2024

Published for Opposition

October 3, 2023

Goods & Services

Medical treatment services; Medical health assessment services; Health counseling; Provision of medical treatment services; Health assessment services; Medical examination services; Medical counseling; Medical equipment rental; Medical testing for diagnostic or treatment purposes; Providing medical information; Advisory services pertaining to pharmacology; Health care; Physical examination services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical screening; Hospital services; Medical and health clinic services relating to DNA, genetics and genetic testing; Genetic testing for medical purposes; Genetic counseling; Medical services; Genetic testing for medical diagnostic or medical treatment purposes; Remote monitoring of medical data for medical diagnosis and treatment

Bacterial preparations other than for medical and veterinary use; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Industrial chemicals; Biological preparations for use in industry and science, other than for medical or veterinary purposes; Chemical preparations for scientific purposes, other than for medical or veterinary use; Cultures of microorganisms, other than for medical and veterinary use; Chemicals for use in science; Nucleic acid amplification reagents other than for medical and veterinary purposes; Reagents in kit form for conducting enzyme-linked immunosorbent assays (elisa) for use in scientific research, other than for medical or veterinary purposes; Chemical reagents for genetic identity testing for non-medical purposes; Chemical reagents for use in diagnostic tests, other than for medical or veterinary use; Chemical reagents for use in analytical tests, other than for medical or veterinary use; Chemical reagents for non-medical purposes; Enzymes for detecting proteins, other than for medical use, for use in the early detection of cancers; Biochemical testing reagents other than for medical purposes; Chemical reagents for laboratory use, other than for medical or veterinary use; Chemical reagents for use in genetic research, other than for medical or veterinary purposes; Testing reagents for liquid biopsy for scientific use, other than for medical or veterinary use; Kits comprising chemicals for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids and biological and biochemical sample material, in particular comprising chemicals for reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification, sequencing and analysis, not for medical purposes, for laboratory or research use; Clinical diagnostic reagents for scientific or research use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Chemical, biochemical and biotechnological products for commercial and scientific use, namely, buffer solutions for use in analytical chemistry, nucleic acids for laboratory use, nucleic acid derivatives and proteins for chemical analysis; Clinical diagnostic reagents for medical use

Research and development for biotechnological and medical research purposes in the field of cancer early detection; Biochemical research and analysis; Advisory services relating to the custom design and development of chemical reagents; Scientific research in the nature of conducting clinical trials for others for pharmaceutical products; Providing information about the results of clinical trials for pharmaceutical products; Scientific research in the nature of conducting clinical trials for others; science and technological services, namely, research in the field of medicine, medical and biological technologies; Scientific laboratory services; Scientific research in the field of genetics; Scientific research relating to genetics; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical research; Product quality testing; Research and development of new products for others; Chemical research; Chemical analysis; Genetic testing for scientific research purposes; Scientific research in the field of genetics and genetic engineering; Rental of laboratory apparatus and instruments; Computer software consultancy; Maintenance of computer software; Monitoring of computer systems by remote access to protect data and information from unauthorized access; Medical laboratory services for the analysis of samples taken from patients

Enzyme preparations for medical purposes; Bacterial preparations for medical purposes; medical diagnostic assays for testing of bodily fluids and tissue in the detection, monitoring, and prediction of disease or other conditions, disease states, hormone level, drug level, drug response, organ function effectiveness, and clinical response; Reagents for use in diagnostic tests for medical purposes; Diagnostic biomarker reagents for medical purposes; Reagent paper for medical purposes; Chemical test reagents for medical use; chemical reagents for medical purposes, namely, diagnostic medical reagent strips for use by individuals to test their own body fluids and for use by the medical profession; Reagents for use in medical genetic testing; Genetic identity tests comprised of reagents for medical purposes; Medical diagnostic reagents and assays for testing of body fluids; nucleic acid sequences and chemical reagents for medical purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 12, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 12, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 23, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 23, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 19, 2025 SUPC
TEAS STATEMENT OF USE RECEIVED
May 14, 2025 EISU
USE AMENDMENT FILED
May 13, 2025 IUAF
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 6, 2025 EXRA
SOU EXTENSION 2 GRANTED
Feb 5, 2025 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 5, 2025 AITU
SOU EXTENSION 2 FILED
Nov 17, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 17, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 25, 2024 EXRA
SOU EXTENSION 1 GRANTED
Apr 24, 2024 EX1G
SOU EXTENSION 1 FILED
Apr 24, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 24, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 28, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 3, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 3, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 13, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 30, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 29, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 29, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 29, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 22, 2023 GNRN
NON-FINAL ACTION E-MAILED
Aug 22, 2023 GNRT
NON-FINAL ACTION WRITTEN
Aug 22, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 22, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 25, 2022 NWOS
NEW APPLICATION ENTERED
Nov 10, 2022 NWAP